phrykt

Caris Life Sciences, Inc. (CAI): who owns it and who trades it

As of Nov 16, 2026, CAI insiders reported 7 open-market sales worth $28.9M and 2 purchases worth $1.5M in the last 12 months, with 6% of the sale value made under pre-set 10b5-1 plans. The largest seller was David Baxley Spetzler (President), with $14.8M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Caris Life Sciences

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns CAI

244 funds and institutions reported CAI shares worth $2.6B at the end of Q2 2026, about 52% of the company. The largest holder is FMR LLC (Fidelity) with 10.9%.

Funds and institutions (13F) 52%Everyone else 48%

10 largest owners, by share of the company

FMR LLC (Fidelity)10.9%
J. H. Whitney Equity Partners VI, LLC4.0%
Coatue Management LLC3.5%
Braidwell LP2.9%
PointState Capital LP2.4%
JPMorgan Chase & Co2.3%
BlackRock, Inc.2.0%
T. Rowe Price Investment Management, Inc.1.8%
Vanguard Portfolio Management LLC1.7%
Vanguard Capital Management LLC1.5%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
FMR LLC (Fidelity)30.92M10.94%$551M+0%
J. H. Whitney Equity Partners VI, LLC11.26M3.98%$201M-38%
Coatue Management LLC9.82M3.48%$175MNo change
Braidwell LP8.26M2.92%$147M+3%
PointState Capital LP6.83M2.42%$122M-7%
JPMorgan Chase & Co6.56M2.32%$120M–
BlackRock, Inc.5.54M1.96%$98.7M+14%
T. Rowe Price Investment Management, Inc.5.08M1.80%$90.5M-9%
Vanguard Portfolio Management LLC4.84M1.71%$86.3M+29%
Vanguard Capital Management LLC4.28M1.51%$76.3M+29%
Los Angeles Capital Management LLC3.96M1.40%$70.5M+73%
Neuberger Berman Group LLC3.59M1.27%$64MNo change
Orbimed Advisors LLC2.81M0.99%$50MNo change
BNP Paribas Financial Markets2.37M0.84%$42.2M+47%
Millennium Management LLC2.20M0.78%$39.3M+44%
Mak Capital One LLC1.94M0.69%$34.5M–
Morgan Stanley1.94M0.68%$34.5M+79%
Duquesne Family Office LLC1.89M0.67%$33.8MNo change
Clearbridge Investments, LLC1.60M0.56%$28.4M+3%
FIL Ltd1.55M0.55%$27.6M+0%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, CAI insiders reported $1.5M of open-market purchases and $28.9M of sales. 6% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$1.5M
2 trades, 2 people
Sales, 12 months
$28.9M
7 trades, 4 people
Sales under a 10b5-1 plan
6%
Share of sale value
Latest trade
Sep 22, 2026
Filed Sep 23, 2026

Purchases and sales by month

$27.2M$27.2MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 22, 2026John Russel DentonSee RemarksSale7,500$31.82$239KForm 4
Sep 17, 2026Brian J BrilleDirectorSale400,000$30.33$12.1MForm 4
Sep 4, 2026David Baxley SpetzlerPresidentSale119,212$24.76$3MForm 4
Sep 3, 2026David Baxley SpetzlerPresidentSale393,100$24.76$9.7MForm 4
Sep 3, 2026David Baxley SpetzlerPresidentSale84,900$25.32$2.1MForm 4
May 15, 2026Jon HalbertDirectorPurchase68,000$14.56$990KForm 4
May 11, 2026Jeff L VacircaDirectorPurchase31,050$16.15$501KForm 4
Dec 11, 2025Luke Thomas PowerSee RemarksSale plan1,400$27.16$38KForm 4
Dec 11, 2025Luke Thomas PowerSee RemarksSale plan60,850$26.56$1.6MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
David Baxley SpetzlerPresident–$14.8MSep 4, 2026
Brian J BrilleSee Remarks, Director–$12.1MSep 17, 2026
Luke Thomas PowerSee Remarks–$1.7MDec 11, 2025
Jon HalbertDirector$990K–May 15, 2026
Jeff L VacircaDirector$501K–May 11, 2026
John Russel DentonSee Remarks–$239KSep 22, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CAI short interest

Low short interest. 4.1% of CAI shares are sold short: about 1 share in 25. Over the last 12 reports the number of shares short went down 2%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 11.49M CAI shares were sold short, 4.1% of the shares outstanding, down 15.4% from the report before. At the average daily volume of 2.89M shares, buying them all back would take about 4.0 trading days (days to cover).

Shares short, % of all shares

4.07%May 15Oct 305.52%

Days to cover

4.0May 15Oct 304.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202611.49M4.07%-15%2.89M4.0
Oct 15, 202613.59M4.81%-2%4.21M3.2
Sep 30, 202613.89M4.92%+4%5.59M2.5
Sep 15, 202613.33M4.72%-3%4.43M3.0
Aug 31, 202613.68M4.84%-8%5.59M2.5
Aug 14, 202614.95M5.29%+1%5.89M2.5
Jul 31, 202614.76M5.22%+26%3.51M4.2
Jul 15, 202611.73M4.15%-17%3.46M3.4
Jun 30, 202614.18M5.02%+22%3.27M4.3
Jun 15, 202611.64M4.12%+8%2.62M4.4
May 29, 202610.73M3.80%-9%2.59M4.2
May 15, 202611.75M4.16%-8%3.69M3.2

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Caris Life Sciences company events

Caris Life Sciences filed 8 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Sep 14, 2026AnnouncementShared information with investors. Filing
  3. Aug 5, 2026ResultsReleased financial results. Filing
  4. Jun 5, 2026VoteReported shareholder vote results. Filing
  5. May 7, 2026ResultsReleased financial results. Filing
  6. Apr 2, 2026AgreementCaris Life Sciences, Inc., a Texas corporation entered into a Financing Agreement, dated as of the Closing Date, by and among the Company, as borrower, certain subsidiaries of the Company, as guarantors, the lenders from time to time party thereto, which consist of funds managed by Blue Owl Capital… Filing
  7. Feb 26, 2026ResultsReleased financial results. Filing
  8. Jan 12, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Caris Life Sciences financials

Famous investors that hold CAI

4 of the 50 well-known investors we track reported holding CAI in their latest 13F filing. The largest position is Israel Englander's, worth $47.9M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 20261.57M$47.9M0.0%-29%
Jim Simons · Renaissance TechnologiesQ3 2026656,500$20.1M0.0%+16%
Ken Griffin · Citadel AdvisorsQ3 2026653,413$20M0.0%+119%
Paul Tudor Jones · Tudor Investment CorpQ3 2026162,974$5M0.0%+62%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named CAI in the last 120 days.

FiledHolderFormStake
Nov 5, 2026FMR LLC13G/A13.4%
Nov 5, 2026FMR LLC13G/A13.4%

Questions about Caris Life Sciences, Inc. (CAI) stock

Who owns the most CAI stock?

The largest reported owner of Caris Life Sciences, Inc. (CAI) is FMR LLC (Fidelity), with 10.9% of the company. In total, 244 funds and institutions reported holding CAI at the end of Q2 2026, together about 52% of the shares. See the largest owners.

Are CAI insiders buying or selling?

In the last 12 months, CAI insiders reported 2 open-market purchases worth $1.5M and 7 sales worth $28.9M. The latest trade was on Sep 22, 2026. See every trade.

What is the short interest in CAI?

As of Oct 30, 2026, 11.49M CAI shares were sold short, 4.1% of the shares outstanding, down 15.4% from the report before. At the average daily volume of 2.89M shares, buying them all back would take about 4.0 trading days (days to cover). See the history.

Which famous investors hold CAI?

4 of the 50 well-known investors we track reported CAI in their latest 13F filing, including Israel Englander, Jim Simons, Ken Griffin. The largest position is worth $47.9M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.